» Articles » PMID: 36553868

Developing an Evidence and Theory Based Multimodal Integrative Intervention for the Management of Renal Cachexia: A Theory of Change

Abstract

In this study, we aimed to develop a theoretical framework for a multimodal, integrative, exercise, anti-inflammatory and dietary counselling (MMIEAD) intervention for patients with renal cachexia with reference to how this addresses the underlying causal pathways for renal cachexia, the outcomes anticipated, and how these will be evaluated. We used a Theory of Change (ToC) approach to guide six steps. Step 1 included inputs from a workshop to obtain key stakeholder views on the potential development of a multimodal intervention for renal cachexia. Step 2 included the findings of a mixed-methods study with Health Care Practitioners (HCPs) caring for individuals with End Stage Kidney Disease (ESKD) and cachexia. Step 3 included the results from our systematic literature review on multimodal interventions for cachexia management. In step 4, we used the body of our research team's cachexia research and wider relevant research to gather evidence on the specific components of the multimodal intervention with reference to how this addresses the underlying causal pathways for renal cachexia. In steps 5 and 6 we developed and refined the ToC map in consultation with the core research team and key stakeholders which illustrates how the intervention components of MMIEAD interact to achieve the intended long-term outcomes and anticipated impact. The results of this study provide a theoretical framework for the forthcoming MMIEAD intervention for those with renal cachexia and in subsequent phases will be used to determine whether this intervention is effective. To the best of our knowledge no other multimodal intervention trials for cachexia management have reported a ToC. Therefore, this research may provide a useful framework and contribute to the ongoing development of interventions for cachexia management.

Citing Articles

The lived experience of renal cachexia: An interpretive phenomenological analysis.

Blair C, Shields J, Mullan R, Johnston W, Davenport A, Fouque D Int J Nurs Stud Adv. 2024; 7:100235.

PMID: 39328835 PMC: 11426076. DOI: 10.1016/j.ijnsa.2024.100235.

References
1.
Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L . A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2007; 73(4):391-8. DOI: 10.1038/sj.ki.5002585. View

2.
Cheung W, Paik K, Mak R . Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol. 2010; 25(4):711-24. DOI: 10.1007/s00467-009-1427-z. View

3.
Cheung W, Zheng R, Hao S, Wang Z, Gonzalez A, Zhou P . The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia. Sci Rep. 2021; 11(1):15141. PMC: 8302616. DOI: 10.1038/s41598-021-94565-y. View

4.
Dixit M, Doan T, Kirschner R, Dixit N . Significant Acute Kidney Injury Due to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting. Pharmaceuticals (Basel). 2016; 3(4):1279-1285. PMC: 4034033. DOI: 10.3390/ph3041279. View

5.
Hung A, Booker C, Ellis C, Siew E, Graves A, Shintani A . Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients. Nephrol Dial Transplant. 2014; 30(2):266-74. PMC: 4309191. DOI: 10.1093/ndt/gfu283. View